Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Total 13F shares
-
28,362,106
-
Share change
-
+3,831,621
-
Total reported value
-
$1,468,602,926
-
Put/Call ratio
-
144%
-
Price per share
-
$51.77
-
Number of holders
-
131
-
Value change
-
+$198,969,370
-
Number of buys
-
90
-
Number of sells
-
28
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q4 2014
As of 31 Dec 2014,
PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by
131 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,362,106 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BROOKSIDE CAPITAL MANAGEMENT LLC, BB Biotech AG, CREDIT SUISSE AG/, VANGUARD GROUP INC, Sectoral Asset Management Inc, BlackRock Fund Advisors, GRANAHAN INVESTMENT MANAGEMENT INC/MA, and WESTFIELD CAPITAL MANAGEMENT CO LP.
This page lists
131
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.